Skip to main content
Signal8

Fresenius Medical Care AG (FMCQF)

Sector: Services-Misc Health & Allied Services, NEC

Fresenius Medical Care AG logo

Fresenius Medical Care AG

+9.16%$47.84
CLOSED
Mkt Cap$24.83B
Float180.93M
O/S519.02M
VOL26K sh
$ Vol$1.23M
RVOL2.93×
Inst Own-
Div Yield3.61%
Dilution
Fresenius Medical Care AG logoOTC:FMCQFClosed$47.84+9.16%
Historical Data
DateOpenHighLowCloseVolume
Nov 5, 202647.8447.8447.8447.8426,150
Oct 16, 202643.8243.8243.8243.82499
Oct 9, 202640.8140.8140.8140.81148
Oct 7, 202642.3742.3742.3742.37100
Oct 6, 202644.3044.3044.3044.302,000
Sep 24, 202644.5844.5844.5844.582,630
Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
Not available
Ratings Distribution
BUY
7
HOLD
9
SELL
0
TOTAL16
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(0)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Issuer-wide via FMS
8.7%
Institutional
(233)
0.0%
Insider
(0)
12.9%
5%+ Owners
(1)
Sources:
About

Fresenius Medical Care AG & Co. KGaA specializes in comprehensive kidney dialysis treatment and associated services, operating across Germany, North America, and numerous international territories. Through an extensive network of outpatient clinics, it delivers essential dialysis therapy along with laboratory and diagnostic support. For home-based care, the company supplies necessary equipment, provides comprehensive training, and offers ongoing patient assistance, including clinical oversight and coordinating supply deliveries directly to patients. In the United States, Fresenius Medical Care also contracts with hospitals to provide vital dialysis interventions for hospitalized individuals suffering from end-stage renal disease (ESRD) and acute kidney failure. Beyond services, it is a prominent developer, manufacturer, and distributor of a broad range of dialysis products. This portfolio encompasses polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers and solutions, concentrates, bloodlines, renal pharmaceuticals, and water treatment systems.

Additionally, the company produces non-dialysis medical devices, including acute cardiopulmonary and apheresis products.

Its pharmaceutical division focuses on developing, acquiring, and in-licensing specialized renal medications, distributing these essential drugs and supplies to both individual patients' homes and dialysis centers.

The company also extends its medical offerings to include a variety of specialized services such as vascular, cardiovascular, and endovascular care, operating ambulatory surgery centers for vascular procedures, and providing physician services in nephrology and cardiology. Products are sold directly to dialysis clinics, hospitals, and specialized treatment centers, complemented by sales through local teams, independent distributors, dealers, and agents. By February 23, 2022, Fresenius Medical Care managed an impressive network of 4,171 outpatient dialysis clinics across roughly 150 countries. Established in 1996, the company maintains its headquarters in Bad Homburg, Germany.

Key Metrics
Market Cap$24.83B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

Parent FMS: 8.69% · 233 13F holders

Sector--
Industry--
ExchangeNYSE
CountryDEDE
IPO DateSep 17, 1996
Shares Outstanding519.02M
Authorized Shares
Float180.93M
52-Week Range
$40.81$51.44
$47.84(66th percentile)
Volume
Average Daily Volume13.32K
26.15K today vs 13.32K avg(+96%)

30d Avg

13.32K

60d Avg

5.25K

90d Avg

4.52K

Earnings
Dividend History
TTM Yield
3.61%
Paid annually
Annual (LTM)
$1.73
Latest
$1.7288
May 22, 26
5Y Growth
+1.06%
per year
Compliance Status
Loading compliance data...